A molecular signature in blood identifies early Parkinson’s disease

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

(2011) Brit Mollenhauer et al.   LANCET NEUROLOGY

Cerebrospinal fluid amyloid   and tau in LRRK2 mutation carriers

(2011) J. O. Aasly et al.   NEUROLOGY

DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease

(2010) Zhen Hong et al.   BRAIN

Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson’s disease

(2010) Edna Grünblatt et al.   JOURNAL OF NEURAL TRANSMISSION

Detection of elevated levels of  -synuclein oligomers in CSF from patients with Parkinson disease

(2010) T. Tokuda et al.   NEUROLOGY

SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease

(2010) Lina A. Shehadeh et al.   PLoS One

Plasma Protein Biomarkers for Depression and Schizophrenia by Multi Analyte Profiling of Case-Control Collections

(2010) Enrico Domenici et al.   PLoS One

PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease

(2010) B. Zheng et al.   Science Translational Medicine

Mendelian forms of Parkinson's disease

(2009) Thomas Gasser   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

A Sporadic Parkinson Disease Model via Silencing of the Ubiquitin-Proteasome/E3 Ligase Component SKP1A

(2009) Tali Fishman-Jacob et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Biological fluid biomarkers in neurodegenerative parkinsonism

(2009) Michael Eller et al.   Nature Reviews Neurology

Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease

(2008) Michael A. Schwarzschild   ARCHIVES OF NEUROLOGY

Quantitative Real-Time PCR Detection of TRPV1–4 Gene Expression in Human Leukocytes from Healthy and Hyposensitive Subjects

(2008) Giacomo Spinsanti et al.   Molecular Pain